Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allos Therapeutics says FDA advisory committee will review lymphoma drug in September
Allos Therapeutics says FDA advisory committee will review lymphoma drug in September
Allos Therapeutics says FDA advisory committee will review lymphoma drug in September
Submitted by
admin
on August 10, 2009 - 11:24am
Source:
Yahoo/AP
News Tags:
FDA
Allos
lymphoma
Pralatrexate
Headline:
Allos Therapeutics says FDA advisory committee will review lymphoma drug in September
Do Not Allow Advertisers to Use My Personal information
